BOLT BIOTHERAPEUTICS INC
BOLTNASDAQ🏆 #3771 by market capEarnings Aug 12US Equity
$598.23▲ $18.72 (+3.13%)
Simulated price1h—
24h▲ 3.1%
7d—
14d—
30d—
1y—
🏦Market Cap
$8M
Small Cap
📈Revenue Growth (YoY)
+78.6%
High Growth
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
1.2x
Cheap
Otter Score
58
Weak
No chart data available for BOLT.
Trading Snapshot
- Day Range
- $593.53 – $601.85
- 52-Week Range
- $3.75 – $7.20
- Volume
- $2.93B
- Avg Volume
- $3.77B
- Shares Outstanding
- 1.9M
- Next Earnings
- Sep 10, 2026
Fundamentals Snapshot
- Annual Revenue
- $6M
- Last Q Revenue
- $2M
- P/E Ratio
- —
- P/S Ratio
- 1.2x
- EPS (TTM)
- $-16.34
- Dividend Yield
- —
Why Investors Own BOLT
- ✓High-growth profile — revenue up -8.7% YoY with expanding US Equity exposure.
- ✓Healthy economics — 78% gross margin and 12% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
⚠️ Key Risks
Execution delays, intensifying competition, and valuation compression if growth decelerates.
Financial Trends
Revenue (TTM)
$6M▼ −6.6% YoY
Gross Margin (TTM)
77.7%▲ +2.5% YoY
Operating Income (TTM)
$2M▼ −6.6% YoY
Free Cash Flow (TTM)
$777,944▼ −6.6% YoY
About BOLT BIOTHERAPEUTICS INC
A company profile for BOLT BIOTHERAPEUTICS INC isn’t available yet — check back soon.
🦦
Otter Score Breakdown
ⓘ💎Quality★★★★★
🚀Growth★★★★★
⚖️Valuation★★★★★
⚡Momentum★★★★★
Overall Score
Weak
58/100
Analyst Price Target
ⓘAverage Target
$679.13
▲ +13.5% Upside
High Target$851.76
Low Target$545.76
Based on 17 analysts
Latest News & Updates
🚀
Reuters·2h ago
BOLT BIOTHERAPEUTICS INC tops quarterly estimates as demand accelerates
Revenue grew double digits with management guiding above consensus; margins continued to expand.
🛰️
Bloomberg·5h ago
Analysts lift BOLT price targets on improving margins
Several firms raised targets, citing stronger free cash flow and a healthier backlog.
🌌
CNBC·1d ago
BOLT BIOTHERAPEUTICS INC announces new agreement to expand its footprint
The move broadens the company’s reach and could add incremental revenue over the next year.